Acrivon Therapeutics, Inc., a clinical-stage biopharmaceutical company, discovers and develops oncology medicines for patients whose tumors are predicted to be sensitive to each specific medicine by utilizing its generative phosphoproteomic...
Leadership
Peter Blume-Jensen M.D., Ph.D.Founder
Co-Founder, Chairman of the Board, CEO, President & Acting Chief Scientific Officer
Kristina Masson M.B.A., Ph.D.Founder
Co-Founder, Executive VP of Business Operations, Site Head, Treasurer & Director
Eric J. Devroe Ph.D.
Chief Operating Officer
Adam D. Levy M.B.A., Ph.D.
CFO & Principal Financial Officer
Katharine Peterson CPA
Vice President of Finance & Accounting
Bruce Close
Vice President of Quality & Compliance
Mary-Alice Miller J.D.
Chief Legal Officer & Corporate Secretary
Erick Gamelin M.D., Ph.D.
Chief Development Officer
Jesper V. Olsen Ph.D.Founder
Academic Co-Founder, Head of Phosphoproteomics & Member of Scientific Advisory Board
